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Phosphorus magnetic resonance 
spectroscopy in the investigation of temporal 
lobe epilepsy: ‘reading between the lines’ of 
metabolic abnormalities
Espectroscopia de fósforo por ressonância magnética na investigação de epilepsia do 
lobo temporal: ‘lendo nas entrelinhas’ das alterações metabólicas
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The natural course of mesial temporal lobe epilepsy (MTLE) is usually associated with a precipitating injury in childhood, which later develops to become the most common form of focal epilepsy in adulthood1. Hippocampal sclerosis (HS) is the main underlying lesion detected in both histopathology and magnetic resonance 
imaging (MRI) evaluation of these patients. A significant proportion of patients MTLE be-
come refractory to antiepileptic drugs (AEDs). Surgery is the most effective treatment in this 
scenario, with the majority of patients becoming seizure free postoperatively. However, there 
are many open questions about the neurobiology of MTLE. Focusing on brain imaging, for ex-
ample, most MTLE patients present with HS although in some the MRI is negative2. Moreover, 
not only the hippocampus seems to be involved in the physiopathology of TLE but also extra-
temporal regions2,3. Besides, for surgical treatment to succeed is mandatory to correctly lat-
eralize seizure focus, which is more complex in MRI negative patients. Magnetic resonance 
spectroscopy (MRS) ist an important tool in the investigation of these broader and subtle 
changes that are missed by structural MRI techniques. Exploiting the magnetic properties of 
several nuclei, MRS is a useful tool when it comes to provide metabolic information in vivo 
without invasive intervention. The most common is proton magnetic resonance spectrosco-
py (1H-MRS), due to 1H natural abundance in biological tissues2. Phosphorus MRS (31P-MRS) 
is not so commonly employed in brain tissue evaluation; nevertheless, it is able to add im-
portant information about energy metabolism. The metabolites visible in a high resolution 
spectrum from 31P-MRS are basically phosphorus compounds: total adenosine triphosphate 
(total ATP, composed by γ- + α- + β-ATP, according to the position of the three phosphate 
groups), inorganic phosphate (Pi), PCr (phosphocreatine), phosphodiesters (PDE, the sum of 
glycerophosphocholine plus glycerophosphoethanolamine) and phosphomonoesters (PME, 
composed by phosphocholine plus phosphoethanolamine)4. These metabolites are mainly in-
volved in mitochondrial processes and cellular membrane turnover. Fewer studies addressed 
the issue of metabolic changes in epilepsy using 31P-MRS than those using 1H-MRS. Data from 
1H-MRS show a decrease in N-acetyl aspartate (NAA) referred as a result of neuronal loss 
and/or neuronal mitochondrial dysfunction, in other words, energy metabolism disturbance. 
NAA decrease is a key finding in several types of epilepsy, often associated with the lateral-
ization of seizure focus and AED response2. Since mitochondria are the energetic engine of 
the cell, further evaluation of brain energy metabolism may help to shed lights on seizures 
underlying mechanisms. In spite of having less spatial resolution than 1H-MRS, studies on 
31P-MRS show that it is able to lateralize the seizure focus and also to characterize the role of 
brain energy metabolism alterations in MTLE5,6. In this issue of Arquivos de Neuro-Psiquiatria, 
Park et al.7 showed abnormal metabolism as measured by 31P-MRS in extratemporal areas in 
patients with MTLE. Evidences from MRS and other imaging modalities give support for the 
more widespread functional impairment extending beyond the mesial temporal structures 
in patients with MTLE6,8. More detailed high-resolution quantitative MRI analyses reveals a 
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network of gray matter atrophy and dysfunction that involves 
mesial temporal and other structures interconnected with the 
limbic system, including thalamus and striatum9; a finding that 
was expanded further by the study of Park et al.7.  The authors 
studied a significant number (n = 33) of well-defined patients 
with refractory seizures and MRI signs of HS and compared 
to 31 healthy controls. They performed multivoxel 31P-MRS in 
the anterior insula-basal ganglia (AIBG), posterior insula-basal 
ganglia (PIBG) and frontal lobes (FL), finding differences in Pi, 
the ratio PCr/ γ-ATP, total ATP and γ-ATP in the patients group 
when compared to controls. The metabolites changes were 
found in all regions studied although less pronounced in FL. 
The authors hypothesized that Pi decrease could be a compen-
satory mechanism observed in the interictal period as a con-
sequence of the high energy demand during the ictal phase. In 
fact, these data support the underlying basis of the metabolic 
disturbance found in 1H-MRS and FDG-PET studies8,9,10. The 
study of Park et al.7 lacks a clinical correlation with 31P-MRS 
findings, as the authors recognize. The work of Park et al.7 re-
kindles the use of brain 31P-MRS for the study of dysfunctions 
in brain metabolism related to epilepsy, and in particular to 
MTLE. Further studies are necessary to elucidate better the re-
lationships of the 31P-MRS abnormalities with seizures, use of 
AEDs, structural damage and other clinical variables.
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